Molecule Details
InChIKeyJOGKUKXHTYWRGZ-UHFFFAOYSA-N
Compound NameDactolisib
Canonical SMILESCn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21
Clinical Status Data-mined Candidate
Targets (Human+Pathogen)28
Pfam Stratification Cross-Family
Avg pChEMBL7.12
SourceChEMBL;BindingDB
2D Structure
2D structure
Activity Profile
DrugBank Annotations
DrugBank ID DB11651
Drug NameDactolisib
CAS Number915019-65-7
Groups investigational
ATC Codes nan
DescriptionDactolisib has been used in trials studying the treatment of Cancer, Solid Tumor, Renal Cancer, Breast Cancer, and Cowden Syndrome, among others.

Categories: Antineoplastic Agents Heterocyclic Compounds, Fused-Ring
Cross-references: BindingDB: 92862 ChEBI: 71952 CHEMBL1879463 ChemSpider: 10151099 PubChem:11977753 PubChem:347828022 Wikipedia: Dactolisib ZINC: ZINC000024760115
Target Activities (28)
Target Gene Organism Category Pfam pChEMBL Type Source
P78527 PRKDC Homo sapiens Human PF20500 PF20502 PF08163 PF19704 PF02259 PF02260 PF00454 8.9 IC50 ChEMBL
Q9UBN7 HDAC6 Homo sapiens Human PF00850 PF02148 8.7 IC50 ChEMBL;BindingDB
Q13315 ATM Homo sapiens Human PF02259 PF02260 PF00454 PF11640 8.2 IC50 ChEMBL;BindingDB
P42345 MTOR Homo sapiens Human PF02259 PF02260 PF08771 PF23593 PF11865 PF00454 7.8 IC50 ChEMBL;BindingDB
P42336 PIK3CA Homo sapiens Human PF00454 PF00792 PF02192 PF00794 PF00613 7.8 IC50 ChEMBL;BindingDB
Q13535 ATR Homo sapiens Human PF02259 PF02260 PF23593 PF25030 PF25032 PF00454 PF08064 7.7 IC50 ChEMBL
O00329 PIK3CD Homo sapiens Human PF00454 PF00792 PF02192 PF00794 PF00613 7.6 IC50 ChEMBL;BindingDB
P48736 PIK3CG Homo sapiens Human PF00454 PF00792 PF00794 PF00613 PF19710 7.6 IC50 ChEMBL;BindingDB
Q9HAZ1 CLK4 Homo sapiens Human PF00069 7.5 Ki ChEMBL
O00443 PIK3C2A Homo sapiens Human PF00168 PF00454 PF00792 PF00794 PF00613 PF00787 7.5 IC50 ChEMBL;BindingDB
O00750 PIK3C2B Homo sapiens Human PF00168 PF00454 PF00792 PF00794 PF00613 PF00787 7.4 IC50 ChEMBL;BindingDB
Q8N122 RPTOR Homo sapiens Human PF02985 PF14538 PF00400 7.4 IC50 ChEMBL
Q9BVC4 MLST8 Homo sapiens Human PF00400 7.4 IC50 ChEMBL
O14757 CHEK1 Homo sapiens Human PF00069 7.3 Ki ChEMBL
Q12851 MAP4K2 Homo sapiens Human PF00780 PF00069 7.3 Ki ChEMBL
P42338 PIK3CB Homo sapiens Human PF00454 PF00792 PF02192 PF00794 PF00613 7.1 IC50 ChEMBL;BindingDB
P27986 PIK3R1 Homo sapiens Human PF16454 PF00620 PF00017 7.1 IC50 ChEMBL;BindingDB
Q8WYR1 PIK3R5 Homo sapiens Human PF10486 7.0 IC50 ChEMBL
P07333 CSF1R Homo sapiens Human PF00047 PF25305 PF07714 6.5 Ki ChEMBL
P29376 LTK Homo sapiens Human PF12810 PF07714 6.5 Ki ChEMBL
Q8NEB9 PIK3C3 Homo sapiens Human PF00454 PF00792 PF00613 6.3 IC50 ChEMBL;BindingDB
P50613 CDK7 Homo sapiens Human PF00069 6.3 Ki ChEMBL
Q9Y4K4 MAP4K5 Homo sapiens Human PF00780 PF00069 6.3 Ki ChEMBL
P08581 MET Homo sapiens Human PF07714 PF01437 PF01403 PF01833 6.1 Ki ChEMBL
P53667 LIMK1 Homo sapiens Human PF00412 PF00595 PF07714 6.1 Ki ChEMBL
Q9UM73 ALK Homo sapiens Human PF12810 PF00629 PF07714 6.1 Ki ChEMBL
P52333 JAK3 Homo sapiens Human PF18379 PF18377 PF17887 PF07714 PF21990 6.0 IC50 ChEMBL;BindingDB
Q5S007 LRRK2 Homo sapiens Human PF23745 PF23744 PF23748 PF16095 PF25497 PF13855 PF00069 PF08477 6.0 Ki ChEMBL
DrugBank Target Actions (2)
Target Gene Target Name Action Type
P42345 MTOR Serine/threonine-protein kinase mTOR modulator targets
P48736 PIK3CG Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform modulator targets